First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and met...

por Leidner, Rom, Conlon, Kevin, McNeel, Douglas G, Wang-Gillam, Andrea, Gupta, Sumati, Wesolowski, Robert, Chaudhari, Monica, Hassounah, Nadia, Lee, Jong Bong, Ho Lee, Lang, O’Keeffe, Jessica A, Lewis, Nancy, Pavlakis, George N, Thompson, John A
Publicado 2023